These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 28986670)
1. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial. Kashkouli MB; Yousefi S; Nojomi M; Sanjari MS; Pakdel F; Entezari M; Etezad-Razavi M; Razeghinejad MR; Esmaeli M; Shafiee M; Bagheri M Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):209-218. PubMed ID: 28986670 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. Pakravan M; Esfandiari H; Sanjari N; Ghahari E Am J Drug Alcohol Abuse; 2016 Nov; 42(6):633-639. PubMed ID: 27463192 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study. Kashkouli MB; Pakdel F; Sanjari MS; Haghighi A; Nojomi M; Homaee MH; Heirati A Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):731-6. PubMed ID: 20890611 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin as a treatment option for indirect traumatic optic neuropathy: A pilot study. Kumar M; Kowsalya A; Narayanamoorthy J; Kumarasamy D; Chitradevi ; Balakrishnan H; Chaudhary S Indian J Ophthalmol; 2023 Jan; 71(1):235-240. PubMed ID: 36588242 [TBL] [Abstract][Full Text] [Related]
5. A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy. Entezari M; Esmaeili M; Yaseri M Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1309-13. PubMed ID: 24986593 [TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Entezari M; Rajavi Z; Sedighi N; Daftarian N; Sanagoo M Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1267-71. PubMed ID: 17265030 [TBL] [Abstract][Full Text] [Related]
7. Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy. Yip CC; Chng NW; Au Eong KG; Heng WJ; Lim TH; Lim WK Eur J Ophthalmol; 2002; 12(4):309-14. PubMed ID: 12220002 [TBL] [Abstract][Full Text] [Related]
8. Traumatic optic neuropathy and second optic nerve injuries. Guy WM; Soparkar CN; Alford EL; Patrinely JR; Sami MS; Parke RB JAMA Ophthalmol; 2014 May; 132(5):567-71. PubMed ID: 24744023 [TBL] [Abstract][Full Text] [Related]
9. Clinical profile and visual outcome in patients with traumatic optic neuropathy. Sujithra H; Shah K; Greeshma C Indian J Ophthalmol; 2023 Aug; 71(8):3046-3052. PubMed ID: 37530279 [TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of megadose methylprednisolone and high dose dexamethasone for traumatic optic neuropathy. Chuenkongkaew W; Chirapapaisan N J Med Assoc Thai; 2002 May; 85(5):597-603. PubMed ID: 12188391 [TBL] [Abstract][Full Text] [Related]
11. Visual Outcome after Treatment with High Dose Intravenous Methylprednisolone in Indirect Traumatic Optic Neuropathy. Pokharel S; Sherpa D; Shrestha R; Shakya K; Shrestha R; Malla OK; Pradhananga CL; Pokhrel RP; Shrestha P J Nepal Health Res Counc; 2016 Jan; 14(32):1-6. PubMed ID: 27426704 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of the initial quantified relative afferent pupillary defect in 19 consecutive patients with traumatic optic neuropathy. Alford MA; Nerad JA; Carter KD Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):323-7. PubMed ID: 11642487 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study. Pakravan M; Esfandiari H; Hassanpour K; Razavi S; Pakravan P Curr Eye Res; 2017 Jul; 42(7):1079-1084. PubMed ID: 28632028 [TBL] [Abstract][Full Text] [Related]
14. The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial. Pakravan M; Sanjari N; Esfandiari H; Pakravan P; Yaseri M Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):2043-2048. PubMed ID: 27510295 [TBL] [Abstract][Full Text] [Related]
15. The effect of steroids in combination with optic nerve decompression surgery in traumatic optic neuropathy. Ropposch T; Steger B; Meço C; Emesz M; Reitsamer H; Rasp G; Moser G Laryngoscope; 2013 May; 123(5):1082-6. PubMed ID: 23553638 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human. Acar U; Kucuk B; Sevinc MK; Aykas S; Erdurmus M; Sobaci G Int Ophthalmol; 2018 Jun; 38(3):1021-1025. PubMed ID: 28527030 [TBL] [Abstract][Full Text] [Related]
19. Risk Factor Analysis for the Outcomes of Indirect Traumatic Optic Neuropathy with No Light Perception at Initial Visual Acuity Testing. Lai IL; Liao HT World Neurosurg; 2018 Jul; 115():e620-e628. PubMed ID: 29705230 [TBL] [Abstract][Full Text] [Related]
20. Risk factors affecting the visual outcome in patients with indirect traumatic optic neuropathy. Sefi-Yurdakul N; Koç F Int Ophthalmol; 2018 Aug; 38(4):1647-1652. PubMed ID: 28681279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]